WASHINGTON, DC — The survival benefit for contralateral prophylactic mastectomy among women who do not have a BRCA gene mutation is less than 1% at 20 years, a new computer model suggests. "We hope ...

As National Breast Cancer Awareness Month comes to a close, here are 5 things to note about the prospect of preventive mastectomies for individuals with a high-risk of developing breast cancer. A ...

"Reassuring" data show more breast cancers with surveillance, but no difference in surviva ...

Overall, 71% (n = 684) of eligible women responded to the mailed survey. Of those who responded to the survey, 81% (n = 554) responded to one or both of the open-ended questions. Of the total 1,067 ...

BRCA mutation carriers have a significantly increased risk of contralateral breast cancer, influencing treatment decisions. Prophylactic mastectomy discussions must consider future fertility and ...

Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer We identified 152,755 patients with stage ...

Phase III Double-Blind Study of Glutamine Versus Placebo for the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy Conclusion: In a clinical setting, we show a high demand ...

The use of contralateral prophylactic mastectomy (CPM), the surgical removal of a breast unaffected by cancer as part of the course of treatment for breast cancer, has more than tripled from 2002 to ...

Choosing between a single mastectomy and double (bilateral) mastectomy for breast cancer can be challenging, and the right decision is different for each person. Medical concerns to weigh include your ...

Breast cancer journeys involve redefining "normal," with advances in reconstruction offering personalized options for patients post-mastectomy. Loss of chest sensation post-mastectomy can impact daily ...